Gemcitabine
Product Description
Omnicap GmbH
-
Country/Region:Switzerland
-
On CPHI since:2017
-
Employees:1 - 24
Company types
Categories
Omnicap GmbH
-
Country/Region:Switzerland
-
On CPHI since:2017
-
Employees:1 - 24
Company types
More Products from Omnicap GmbH (99)
-
Product Erlotinib
Epidermal growth factor receptor tyrosine-kinase inhibitor API used in targeted cancer therapy. -
Product Etoricoxib
Selective COX-2 inhibitor API used for analgesic and anti-inflammatory treatment of musculoskeletal disorders. -
Product Exemestane
Steroidal aromatase inhibitor API used in endocrine treatment of hormone-sensitive breast cancer. -
Product Foscarnet sodium
Pyrophosphate analogue antiviral API used for serious cytomegalovirus and resistant herpesvirus infections. -
Product Ganciclovir
Antiviral nucleoside analogue API used for treatment and prevention of cytomegalovirus infections. -
Product Gefitinib
Epidermal growth factor receptor tyrosine-kinase inhibitor API used in targeted treatment of EGFR-mutated cancers. -
Product Glycerol Phenylbutyrate
Nitrogen-scavenging API used for chronic management of urea-cycle disorders by promoting alternative nitrogen excretion. -
Product Glycofurol Special
Water-miscible pharmaceutical solvent and solubilizing excipient used in liquid and parenteral formulation development. -
Product Halobetasol Propionate
Super-potent topical corticosteroid API used for short-term treatment of inflammatory and pruritic dermatoses. -
Product Haloperidol
Typical antipsychotic API and dopamine D2 receptor antagonist used in psychiatric and acute agitation treatment. -
Product Hexamidine Di Isethionate
Cationic antiseptic and antimicrobial active used mainly in topical skin and mucosal formulations. -
Product Histamine Base
Biogenic amine and histamine-receptor agonist used as a pharmaceutical, diagnostic or biochemical active ingredient.